Fabtech Technologies Ltd
Company Profile
Business description
Fabtech Technologies Ltd is engaged in building pharmaceutical, biotech, and healthcare capabilities for a wide range of customers by offering comprehensive start-to-finish turnkey solutions, which include supplying pharmaceutical machinery/equipment, in-house designing and engineering, procurement, installation, validation, and undertaking other activities required in various projects, including standalone equipment supply and installation. The company provides solutions for clean air, manufacturing processes, purified water and pure steam generation and distribution, etc. The majority of its revenue is generated from the trading of pharmaceutical and surgical products. Geographically, the company derives maximum revenue from international markets, and the rest from its business in India.
Contact
Street 16, MIDC Central Road
Plot No D8, 1st Floor, ABR Emerald
MIDC Andheri East
Chakala MIDC
MumbaiMH400093
INDT: +91 2261592900
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
31 March 2026
Employees
185
Stocks News & Analysis
stocks
Investors overly negative on cheap ASX share
stocks
Overvalued US AI play reports earnings
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,918.30 | 4.70 | 0.05% |
| CAC 40 | 8,151.38 | 0.74 | 0.01% |
| DAX 40 | 24,288.40 | 88.90 | 0.37% |
| Dow JONES (US) | 48,134.89 | 183.04 | 0.38% |
| FTSE 100 | 9,897.42 | 59.65 | 0.61% |
| HKSE | 25,690.53 | 192.40 | 0.75% |
| NASDAQ | 23,307.62 | 301.26 | 1.31% |
| Nikkei 225 | 49,507.21 | 505.71 | 1.03% |
| NZX 50 Index | 13,333.40 | 76.63 | 0.58% |
| S&P 500 | 6,834.50 | 59.74 | 0.88% |
| S&P/ASX 200 | 8,621.40 | 0.10 | -0.00% |
| SSE Composite Index | 3,890.45 | 14.08 | 0.36% |